KFS
XPH icon

Kaizen Financial Strategies’s State Street SPDR S&P Pharmaceuticals ETF XPH Stock Holding History

Kaizen Financial Strategies’s Portfolio XPH Stock Details XPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$228K Buy
+3,500
New +$242K 0.09% 158

Other funds holding XPH

CI
CX Institutional Auburn, Indiana $3.69B AUM 15.82% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
CA
CoreCap Advisors Southfield, Michigan $3.48B AUM 21.43% 1-Year Est. Return

Kaizen Financial Strategies's XPH Position: Q3 2026 in Review

Kaizen Financial Strategies opened a new position in State Street SPDR S&P Pharmaceuticals ETF (XPH) in Q3 2026: 3,500 shares worth $228K. The stake represents 0.09% of the portfolio and ranks #158 among its holdings.

4 funds tracked by Wall St. Rank hold XPH as of Q3 2026.

  • Kaizen Financial Strategies held 3,500 shares of State Street SPDR S&P Pharmaceuticals ETF worth $228K as of Q3 2026.
  • State Street SPDR S&P Pharmaceuticals ETF was a new Kaizen Financial Strategies position in Q3 2026.
  • State Street SPDR S&P Pharmaceuticals ETF made up 0.09% of Kaizen Financial Strategies's portfolio in Q3 2026, its #158 holding.
  • 4 funds tracked by Wall St. Rank held State Street SPDR S&P Pharmaceuticals ETF as of Q3 2026.

Based on Kaizen Financial Strategies's 13F filing for Q3 2026, filed 9 Oct 2026.